BGB-3111-305
Completed
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia
Beigene Study ID 
ClinicalTrials.gov ID
EudraCT Number
China Drug Trials ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? yes
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? yes